Previous 10 | Next 10 |
Image source: The Motley Fool. Seer, Inc. (NASDAQ: SEER) Q2 2022 Earnings Call Aug 09, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Seer, Inc. (SEER) Q2 2022 Earnings Call Transcript
Seer ( NASDAQ: SEER ) stock tumbled 14.6% postmarket Tuesday despite the life sciences firm's largely in-line Q2 results . SEER reported Q2 GAAP EPS of -$0.37 vs. -$0.27 in Q2 2021. Revenue more than doubled to $3.6M, led by higher sales of the Proteograph Pro...
Seer press release ( NASDAQ: SEER ): Q2 GAAP EPS of -$0.37 (vs. -$0.27 Y/Y) beats by $0.01 . Revenue of $3.6M (+170.7% Y/Y) beats by $0.34M . Seer continues to expect full year 2022 revenue to be in the range of $14.0 million to $16.0 million. Consensus estimat...
REDWOOD CITY, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results for the second quarter ended June 30, 2022. “We are building on a strong start t...
REDWOOD CITY, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced a new Proteogenomics Workflow that integrates deep, unbiased proteomics with genomics, powered by the Proteogra...
REDWOOD CITY, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report financial results for the second quarter of 2022 on Tuesday, August 9, 2022. Company management ...
Which of the healthcare producers of Diagnostic Solutions is now a better buy to help build your portfolio’s near-term capital value? Near-term only, repetition provides long term. Here find out what the best-informed, big-$ investors now think is likely to happen (good and bad...
- Leaps by Bayer led Series B investment in Senti Bio in 2021; Additional Convertible Note financing expands committed capital to PIPE investment associated with previously announced Business Combination Agreement with DYNS - - DYNS announces effectiveness of registration statem...
Seer, Inc. (SEER) Q1 2022 Earnings Conference Call May 04, 2022, 05:00 PM ET Company Participants Carrie Mendivil - IR Omid Farokhzad - Founder, Chairman & CEO David Horn - CFO Omead Ostadan - President Conference Call Participants Neil Vibhakar - Morgan Stanley Nisarg Shah - Bank of Amer...
Image source: The Motley Fool. Seer, Inc. (NASDAQ: SEER) Q1 2022 Earnings Call May 04, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Seer, Inc. (SEER) Q1 2022 Earnings Call Transcript
News, Short Squeeze, Breakout and More Instantly...
REDWOOD CITY, Calif., July 18, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the second quarter 2024 on Thursday, August 8, 2024. Company manag...
Secretome profiles from SpaceX Inspiration4 mission show alterations in oxidative stress, brain homeostasis, and coagulation Creation of first-of-its-kind comprehensive atlas of molecular and physiological multiomic profiles available from multiple spaceflight missions REDWOOD CIT...
REDWOOD CITY, Calif., June 02, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, announced today that PrognomiQ has completed the largest and deepest unbiased mass spectrometry plasma biomarker study to da...